Healthcare Realty Trust (HR) Stock Forecast: What Could Drive It in 2026
Last updated July 2026
Short answer
What is actually driving Healthcare Realty Trust (HR) right now is Occupancy and leasing momentum: HR reported record quarterly leasing of more than 2 million square feet in Q1 2026 and same-store occupancy of about 92.3 percent, up roughly 110 basis points year over year. Revenue (TTM) is ~$1.2B. If that keeps playing out, the setup is favourable; the risk to it is as a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. No one can predict where HR trades, and Walnut does not publish targets, so treat this as a scenario, not a price target or prediction.
What could drive Healthcare Realty Trust (HR) higher?
1. Occupancy and leasing momentum
HR reported record quarterly leasing of more than 2 million square feet in Q1 2026 and same-store occupancy of about 92.3 percent, up roughly 110 basis points year over year. Filling vacant medical office space is the most direct lever on cash flow, and continued lease-up would support internal growth without new acquisitions.
2. Same-store cash NOI growth
The company posted same-store cash NOI growth near 6.9 percent in Q1 2026, described as its highest quarterly increase on record. Management raised full-year same-store cash NOI growth guidance toward a roughly 3.75 to 4.75 percent range, reflecting rent escalators and improving occupancy across a large, mostly on-campus medical office portfolio.
3. Deleveraging and balance sheet repair
HR has been selling assets and repaying debt, bringing net debt to adjusted EBITDA to roughly 5.4x with about 98 percent of debt fixed near a 3.2 percent weighted-average rate and around $1.4 billion of liquidity as of late 2025. A stronger balance sheet lowers refinancing risk and gives more flexibility as debt matures.
4. Durable outpatient demand
The long-term thesis rests on the shift of care toward outpatient settings and an aging population, which supports steady demand for medical office space near hospitals. This tenant base tends to renew leases at high rates, giving HR relatively predictable, recurring rental income.
What could weigh on HR?
As a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. Its FFO payout leaves limited cushion, and the dividend has been trimmed in the past, so distribution coverage is worth watching. Integration of the large Healthcare Trust of America portfolio, tenant credit and move-outs, and elevated leverage relative to some peers add execution risk. Asset sales used to cut debt can also dilute near-term earnings power. Any broader weakness in commercial real estate values could weigh on the shares.
Where HR trades today
A forecast starts from where the stock actually is. These are HR's current figures, not a projection: the drivers and risks above are what would move them.
Snapshot for HR as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
How to think about a HR forecast
Rather than chasing a price target, it tends to help to weigh the drivers above against the risks, decide how long you are willing to hold, and size the position so a wrong call is survivable. A “forecast” is really a probability-weighted view of those drivers playing out, not a number.
For the full picture, see the HR guide and whether HR is a buy. In Walnut you can pressure-test the thesis against your real portfolio.
The bottom line on the HR outlook
The bottom line: what is driving Healthcare Realty Trust (HR) is Occupancy and leasing momentum, with revenue (ttm) at ~$1.2B. If that keeps playing out the setup is favourable; the risk is as a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. No one can predict the price, so treat any HR forecast as a scenario, not a target or prediction, and decide from your own thesis and time horizon. Walnut is not an investment adviser.
More on HR
- HR stock guide (what the company does, ETFs that hold it, similar stocks, and the themes it fits)
- Is HR a buy? (the case for, the risks, and a framework to decide)
- Does HR pay a dividend?
Build a basket around HR with Walnut
Use Healthcare Realty Trust as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What is the forecast for Healthcare Realty Trust (HR)?
+
No one can reliably predict where HR will trade, and Walnut does not publish price targets. What is more useful is the setup: the drivers that could push Healthcare Realty Trust higher and the risks that could weigh on it. This page lays out both so you can form your own view. Not a recommendation.
What could drive HR higher?
+
The main growth drivers are Occupancy and leasing momentum; Same-store cash NOI growth; Deleveraging and balance sheet repair. Whether they play out is the real question, not a guaranteed path.
What are the risks to HR?
+
As a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. Its FFO payout leaves limited cushion, and the dividend has been trimmed in the past, so distribution coverage is worth watching. Integration of the large Healthcare Trust of America portfolio, tenant credit and move-outs, and elevated leverage relative to some peers add execution risk. Asset sales used to cut debt can also dilute near-term earnings power. Any broader weakness in commercial real estate values could weigh on the shares.
Will HR stock go up in 2026?
+
Nobody knows, and anyone who says they do is guessing. Healthcare Realty Trust's direction depends on whether the drivers above outweigh the risks, plus the broader market. Focus on the thesis and your time horizon rather than a single-year call.
Is HR a buy?
+
That depends on your thesis, time horizon, and what you already own, not on a forecast. See the HR "is it a buy?" page for a framework. Walnut is not an investment adviser.
Walnut is informational, not investment advice. This page describes drivers and risks; it is not a price forecast, target, or recommendation. Markets are uncertain and past performance does not predict future results.